MEMORANDUM

MEMORANDUM
PRIVILEGED AND CONFIDENTIAL — ATTORNEY WORK PRODUCT
This memorandum is protected by the attorney-client privilege and constitutes attorney work product prepared in anticipation of litigation and in connection with the provision of legal advice. This memorandum and its contents are not to be disclosed to any third party without the prior written authorization of Calderwood & Harkness LLP. Any inadvertent disclosure does not constitute a waiver of privilege.
FROM: Christy Bauer, Working Associate, intellectual Property Calderwood & Harkness LLP 1750 K Street NW, Suite 800 Washington, DC 20006
TO: Beatrice Holloway, Responsible Partner, Mergers & Acquisitions Omar Siddiqui, Lead Associate, intellectual Property Margaret "Peggy" Ashworth, Of Counsel, National Security & CFIUS
DATE: September 8, 2023
RE: Freedom-to-Operate Assessment and Third-Party intellectual Property Risk Analysis — Marlowe Asset Management Photonics Inc. ("VPI") — Acquisition by Halcyon Semiconductor Aktiengesellschaft ("HSAG")
MATTER: Halcyon Semiconductor AG / Marlowe Asset Management Photonics Inc. Acquisition — CFIUS Filing & Related Matters (Matter No. 1014-00001)
PRIVILEGE NOTICE: This memorandum was prepared by counsel at Calderwood & Harkness LLP at the direction of Beatrice Holloway, Responsible Partner, in connection with the firm's representation of Halcyon Semiconductor Aktiengesellschaft in its proposed acquisition of Marlowe Asset Management Photonics Inc. The memorandum reflects the mental impressions, conclusions, opinions, and legal theories of the undersigned attorney and is protected by the attorney-client privilege and the work product doctrine under Fed. R. Civ. P. 26(b)(3) and its state-law equivalents. This memorandum has been prepared in anticipation of potential patent litigation and in connection with the provision of legal advice regarding the proposed transaction. Distribution is restricted to the named recipients and other members of the deal team as authorized by the Responsible Partner.
Right-click to update Table of Contents
I. EXECUTIVE SUMMARY
The purpose of this memorandum is to assess whether Marlowe Asset Management Photonics Inc.'s ("VPI") current and planned gallium-nitride high-electron-mobility transistor ("GaN HEMT") and millimeter-wave ("mmWave") power amplifier product lines create infringement exposure with respect to third-party patent rights, and to identify any freedom-to-operate ("FTO") risks material to Halcyon Semiconductor Aktiengesellschaft's ("HSAG") proposed acquisition of VPI. This analysis has been prepared at the direction of the deal team to support HSAG's acquisition decision-making and to inform any representations, warranties, or indemnification provisions in the Stock Purchase Agreement that may be affected by intellectual property risk.
Scope of Analysis. We conducted a comprehensive search of U.S. Patent and Trademark Office ("USPTO") databases — including granted patents and published applications — covering VPI's core product areas: GaN-on-silicon carbide ("SiC") power amplifiers for defense radar, satellite communications, and 5G infrastructure applications. The search was focused on VPI's two primary product families: (1) GaN HEMT discrete devices and monolithic microwave integrated circuits ("MMICs"), and (2) mmWave broadband power amplifier modules. The search also encompassed VPI's underlying GaN-on-SiC epitaxial wafer processing technology, which is foundational to all VPI products.
Principal Conclusions. Based on our review, we have reached the following conclusions:
1.  No current infringement exposure. We have identified no current infringement exposure with respect to VPI's existing commercial and defense product lines as presently manufactured and sold. VPI's products, as currently configured and produced at VPI's Albuquerque, New Mexico fabrication facility, do not practice any claim of any identified third-party U.S. patent.
2.  Three patent families warrant ongoing monitoring. We have identified three third-party patent families that warrant ongoing monitoring due to their adjacency to VPI's technology. These families are held by Apex Microelectronics Corp. (GaN HEMT diamond thermal management), Wideband Innovations LLC (mmWave broadband matching networks), and Cerulean Semiconductor Technologies Ltd. (GaN epitaxial buffer layer structures). While none of these patent families currently presents an actionable infringement risk, each involves technology areas that are sufficiently proximate to VPI's product roadmap or design architecture to warrant continued attention.
3.  Transaction impact. We do not recommend any adjustment to the transaction valuation or any specific indemnification carve-outs on account of FTO risk. The identified risks are manageable through a routine post-closing patent watch program and periodic re-assessment, the costs of which are modest relative to the transaction value.
4.  Post-closing recommendations. We recommend that VPI implement an ongoing patent watch program following the closing of the transaction to monitor the three identified patent families and any related continuation or divisional applications. We also recommend the preparation of formal design-around memoranda and periodic FTO re-assessments at twelve-month intervals or upon any material change in VPI product designs.
5.  Defensive portfolio leverage. VPI's own portfolio of forty-seven (47) granted and twelve (12) pending U.S. patents — analyzed separately in Omar Siddiqui's VPI Patent Portfolio Summary dated August 22, 2023 — provides a significant degree of defensive cross-licensing leverage in the event any third-party dispute materializes. This portfolio, combined with the government contractor defense available for VPI's substantial government-contract business, further reduces VPI's overall FTO risk profile.
In sum, the FTO landscape for VPI is favorable. The identified risks are speculative and contingent, and they do not rise to a level that should impede or materially affect the transaction.
II. BACKGROUND AND CONTEXT
A. Transaction Overview
Halcyon Semiconductor Aktiengesellschaft ("HSAG"), a publicly traded German semiconductor company listed on the Frankfurt Stock Exchange (XETRA: HLC), with its registered office and principal place of business at Industriestraße 44, 01099 Dresden, Saxony, Germany, is acquiring one hundred percent (100%) of the outstanding equity interests of Marlowe Asset Management Photonics Inc. ("VPI"), a Delaware C-corporation incorporated on February 14, 2009, with its principal offices at 7400 Ridgeline Parkway, Colorado Springs, Colorado 80919.
The aggregate purchase price for the acquisition is $1.42 billion on a cash-free, debt-free basis, with up to $85 million in additional earnout consideration tied to government-contract revenue milestones in calendar year 2024 ($50 million) and calendar year 2025 ($35 million), resulting in maximum aggregate consideration of $1.505 billion. The acquisition is structured as a stock purchase, with HSAG acquiring VPI's equity through its wholly owned U.S. acquisition vehicle, Halcyon US Holdings Inc., a Delaware C-corporation formed on June 5, 2023 for purposes of the transaction.
The Stock Purchase Agreement ("SPA") was executed on June 10, 2023. The transaction is subject to regulatory approval, including review by the Committee on Foreign Investment in the United States ("CFIUS"). A voluntary joint notice was filed with CFIUS on July 14, 2023, and the transaction has been assigned Case No. CFIUS-023-07-3841. The CFIUS review is ongoing, and the parties are currently in the investigation period following the initial forty-five-day review period. Peggy Ashworth's team is managing the CFIUS process and the negotiation of a National Security Agreement ("NSA") and associated Technology Control Plan ("TCP") with the CFIUS monitoring agencies.
This FTO memorandum is part of the broader intellectual property due diligence workstream and is intended to inform both the transactional team and the CFIUS-related national security team regarding third-party IP risks that could affect VPI's operations, valuation, or post-closing structure.
B. VPI's Core Technology and Product Lines
VPI designs and manufactures advanced gallium-nitride ("GaN") power amplifier chips used in three primary application areas: (i) defense radar systems, (ii) satellite communications, and (iii) 5G wireless infrastructure. VPI has established itself as a leading U.S.-based supplier of GaN power amplifier technology, with particular strength in high-reliability defense and aerospace applications.
Manufacturing Capability. VPI operates a 45,000-square-foot GaN-on-SiC fabrication facility located at 9200 Innovation Boulevard, Albuquerque, New Mexico 87113. The facility holds a Facility Security Clearance ("FCL") at the SECRET level, with CAGE Code 7VK92, enabling VPI to perform classified work in support of U.S. Department of Defense ("DoD") programs. The Albuquerque facility houses VPI's metal-organic chemical vapor deposition ("MOCVD") epitaxial growth reactors, wafer fabrication clean room, die-level testing and screening equipment, and module assembly capabilities.
Technology Base. VPI's technology base centers on three core competencies: (a) GaN-on-silicon carbide (SiC) epitaxial growth processes, including proprietary nucleation layer, buffer layer, and barrier layer recipes developed over more than a decade; (b) high-electron-mobility transistor (HEMT) gate structures, including proprietary gate recess etch processes and field-plate designs optimized for high power density and reliability; and (c) mmWave broadband matching network architectures, including proprietary distributed element network topologies that enable wideband operation at frequencies from 18 GHz to 95 GHz.
Export Control Classification. VPI's products include items controlled under both the International Traffic in Arms Regulations ("ITAR") and the Export Administration Regulations ("EAR"). Certain of VPI's defense radar and missile defense products are classified as ITAR Category XI(a)(3) defense articles, subject to State Department licensing requirements. VPI's commercial and dual-use products are classified under EAR Export Control Classification Number ("ECCN") 3A001, which covers certain high-performance semiconductor devices. These classifications are relevant to the CFIUS review and the NSA/TCP framework, and they also bear on the scope of VPI's commercial activities and the markets in which FTO risk must be assessed.
VPI Patent Portfolio. VPI holds forty-seven (47) granted U.S. patents and twelve (12) pending U.S. patent applications, organized in three key patent families:
GaN-on-SiC Epitaxial Growth Process Family. U.S. Patent Nos. 9,XXX,001 through 9,XXX,008 — eight (8) patents with earliest priority date in 2012. These patents cover VPI's proprietary MOCVD epitaxial growth processes, including nucleation layer formation, buffer layer doping profiles, and barrier layer compositions.
HEMT Gate Structure Optimization Family. U.S. Patent Nos. 10,XXX,101 through 10,XXX,119 — nineteen (19) patents with earliest priority date in 2015. These patents cover VPI's proprietary gate recess etch processes, field-plate gate designs, multi-step passivation techniques, and related device-level innovations.
mmWave Broadband Matching Network Family. U.S. Patent Nos. 11,XXX,201 through 11,XXX,220 — twenty (20) patents with earliest priority date in 2018. These patents cover VPI's proprietary broadband impedance matching network topologies, distributed element network designs, and integrated bias sequencing techniques for mmWave power amplifier modules.
Of VPI's forty-seven granted patents, twenty-three (23) were developed under U.S. government-funded contracts and are therefore subject to government license rights under 28 U.S.C. § 1498, march-in rights under 35 U.S.C. § 203 (Bayh-Dole Act), and the patent rights provisions of DFARS 252.227-7038. The implications of these government rights for the transaction are analyzed separately in the Government Rights in Subject Inventions Memo prepared by Omar Siddiqui, dated August 30, 2023.
Trade Secrets. In addition to its patent portfolio, VPI maintains thirty-one (31) registered internal trade secrets, primarily relating to proprietary GaN epitaxial recipes (including specific MOCVD process parameters, gas flow ratios, and temperature profiles) and die-level reliability screening processes (including accelerated life testing protocols and failure analysis methodologies). These trade secrets are catalogued in VPI's internal trade secret register and are subject to VPI's Trade Secret Protection Program, which includes access controls, non-disclosure agreements, and employee exit protocols. The adequacy of VPI's trade secret protections is assessed separately in the Trade Secret Protection Assessment memo.
C. Government Contracts Relevance to FTO Analysis
VPI's government contracting activities are material to the FTO analysis for two reasons: first, they define a substantial portion of VPI's product output and revenue; and second, they provide certain legal protections against patent infringement liability under the government contractor defense.
Active Contracts. VPI currently holds fourteen (14) active DoD contracts with an aggregate backlog of approximately $193 million. The contracting agencies include the U.S. Army Program Executive Office for intelligence, Electronic Warfare & Sensors ("PEO IEW&S"), the Air Force Research Laboratory ("AFRL"), the Missile Defense Agency ("MDA"), the U.S. Navy (via subcontract to Ironclad Defense Systems Inc. under a Naval Sea Systems Command ("NAVSEA") prime contract), and the Department of Homeland Security Science and Technology Directorate ("DHS S&T").
The top five contracts by backlog value are as follows:
Government Contractor Defense. Under 28 U.S.C. § 1498, when a contractor manufactures a product for the U.S. government with the authorization or consent of the government, the patent holder's exclusive remedy is a claim against the United States in the U.S. Court of Federal Claims, rather than a direct infringement action against the contractor. This statutory defense provides significant protection for products manufactured and delivered to the U.S. government under VPI's active DoD contracts. The defense applies to VPI's defense radar modules (AN/TPS-80 program), missile defense T/R modules (MDA program), AFRL next-generation mmWave amplifiers, and other government-contracted deliverables.
Importantly, the 28 U.S.C. § 1498 defense does not extend to VPI's commercial sales, including its 5G infrastructure components sold to commercial wireless carriers and equipment manufacturers. Commercial sales would be subject to standard patent infringement liability in the U.S. district courts.
Given that VPI's government contract backlog of $193 million represents a substantial portion of VPI's total revenue, the § 1498 defense meaningfully reduces VPI's overall FTO risk profile. Nonetheless, the FTO analysis presented in this memorandum has been conducted without reliance on the § 1498 defense, in order to provide the most comprehensive and conservative risk picture for HSAG's acquisition decision-making. The § 1498 defense is discussed further in Section VI below.
D. Scope and Methodology
The FTO analysis described in this memorandum was conducted using the following search methodology:
Patent Database Search. We conducted a comprehensive patent landscape search across USPTO full-text databases, including both granted patents and published applications. The search employed a multi-pronged strategy incorporating: (i) keyword-based searches using terms related to GaN HEMTs, GaN power amplifiers, mmWave amplifiers, GaN-on-SiC epitaxy, and related technical concepts; (ii) Cooperative Patent Classification ("CPC") code-based searches focused on the most relevant classification codes; and (iii) citation-based searches analyzing the backward and forward citations from VPI's own forty-seven granted patents and twelve pending applications.
CPC Classification Focus. The search was focused on the following CPC classes and subclasses:
•  H01L 29/778 — High-electron-mobility transistors (HEMTs) and related device structures
•  H01L 21/02 — Semiconductor manufacturing processes, including epitaxial growth methods
•  H03F 3/60 — Power amplifiers for high frequencies, including microwave and millimeter-wave amplifiers
•  Related subclasses encompassing GaN device fabrication, thermal management structures, impedance matching networks, and RF/microwave circuit design
Prosecution History Review. We reviewed the complete prosecution histories of VPI's twelve pending patent applications and selected prosecution histories from VPI's forty-seven granted patents, with particular attention to prior art cited by USPTO examiners and by VPI during prosecution. This review served dual purposes: identifying third-party patents that the USPTO considered relevant to VPI's own patent claims, and establishing VPI's positions regarding distinctions from prior art that may bear on infringement analysis.
Litigation Docket Review. We reviewed publicly available litigation dockets involving GaN semiconductor and mmWave amplifier patents filed in the three most active patent litigation forums: the U.S. District Court for the District of Delaware, the U.S. District Court for the Eastern District of Texas, and the U.S. District Court for the Western District of Texas. This review was designed to identify any ongoing or recently resolved patent assertion campaigns that could foreshadow future claims against VPI.
Engineering Consultation. We engaged directly with VPI's in-house engineering team, coordinated through Col. (Ret.) Bryce Hendrickson, VPI's Vice President of Government Programs, and VPI's designated patent liaison. VPI's engineers provided detailed technical briefings on VPI's product architectures, manufacturing processes, and R&D roadmap, and assisted with product feature-to-claim mapping for identified third-party patents. These consultations were conducted under the direction of counsel and are protected by the attorney-client privilege.
Temporal Scope. The search covered patents with earliest effective filing dates from 2005 to present, with priority given to patents with expiration dates after 2030 — i.e., patents that would remain enforceable during the period most relevant to HSAG's investment thesis.
Detailed search parameters, including specific keyword strings, CPC code combinations, and citation analysis methodology, are set forth in Appendix 1 to this memorandum.
III. VPI PRODUCT LINE BREAKDOWN FOR FTO PURPOSES
To ensure a thorough and well-organized FTO analysis, we have structured our review around VPI's three principal technology areas. Each is described below with sufficient technical detail to support the claim-comparison analysis presented in Section IV and the claim charts set forth in Appendix 2.
A. GaN HEMT Discrete Devices and Monolithic Microwave Integrated Circuits (MMICs)
Device Architecture. VPI's GaN HEMT devices are based on an aluminum gallium nitride/gallium nitride ("AlGaN/GaN") heterostructure grown on semi-insulating silicon carbide (SiC) substrates. The AlGaN/GaN heterojunction creates a two-dimensional electron gas ("2DEG") at the interface, which provides the high electron mobility and high current density that are characteristic of HEMT devices. VPI's HEMT designs incorporate a field-plate gate structure that extends over the drain-side edge of the gate, reducing peak electric fields and improving breakdown voltage and reliability. VPI's devices also employ proprietary passivation layer innovations — specifically, a multi-step silicon nitride (SiN) passivation process that reduces surface trapping effects and current collapse.
Applications. VPI's GaN HEMT devices are used in three primary application areas: (i) defense radar systems, most notably the AN/TPS-80 multi-mission radar program, for which VPI supplies GaN power amplifier modules; (ii) missile defense transmit/receive (T/R) modules for the MDA program, which require high peak power, wide bandwidth, and extreme reliability; and (iii) commercial base station amplifiers for 5G wireless infrastructure, where GaN HEMTs offer superior power efficiency compared to legacy silicon LDMOS and GaAs technologies.
Key Differentiating Features. For purposes of the FTO analysis, the following technical features of VPI's GaN HEMT products are most relevant to distinguishing VPI's products from third-party patent claims:
(a) Proprietary gate recess etch process. VPI employs a proprietary inductively coupled plasma ("ICP") etch process to form the gate recess in the AlGaN barrier layer. The process parameters — including etch gas chemistry, chamber pressure, and RF power levels — are maintained as trade secrets and produce a gate recess profile that differs from the profiles described in identified third-party patents.
(b) Multi-step passivation. VPI's multi-step SiN passivation process involves sequential deposition of SiN layers with differing stoichiometries and stress characteristics. This approach, covered by VPI's own patents, differs from the single-layer passivation methods described in many third-party patents.
(c) Thermal management at the die level. VPI's current HEMT products rely on direct GaN-on-SiC bonding, with thermal management achieved through conventional backside via holes and die-attach materials (e.g., gold-tin eutectic solder). VPI does not currently incorporate diamond or diamond-like carbon thermal interface layers in its production devices, although VPI's R&D roadmap contemplates investigation of such approaches for future high-power-density applications.
Relevant VPI Patent Coverage. VPI's HEMT gate structure optimization patent family (U.S. Patent Nos. 10,XXX,101 through 10,XXX,119, nineteen patents, earliest priority 2015) provides extensive coverage of VPI's HEMT device architecture and fabrication methods. This patent family serves both an offensive purpose (protecting VPI's technology from imitation by competitors) and a defensive purpose (establishing VPI's freedom to operate within its own claimed technology space and providing cross-licensing leverage in the event of third-party assertions).
B. mmWave Broadband Power Amplifier Modules
Architecture Description. VPI's mmWave broadband power amplifier modules are multi-stage amplifier circuits designed for operation at frequencies ranging from 18 GHz to 95 GHz. The modules incorporate VPI's GaN HEMT devices as the active amplifying elements, combined with proprietary matching network topologies that enable wideband operation across multiple octaves of bandwidth. VPI's amplifier modules are implemented as monolithic microwave integrated circuits (MMICs) fabricated on GaN-on-SiC wafers, with passive matching elements (transmission lines, capacitors, and resistors) integrated on-chip.
Applications. VPI's mmWave broadband power amplifier modules serve three primary markets: (i) satellite communications, including Ka-band (26.5–40 GHz) and V-band (40–75 GHz) uplink amplifiers for both military and commercial satellite terminals; (ii) the AFRL next-generation mmWave power amplifier program, which requires ultra-wideband operation across the 18–50 GHz range for electronic warfare and signals intelligence applications; and (iii) 5G small-cell backhaul applications, where mmWave amplifiers are used in point-to-point wireless links operating at 28 GHz and 39 GHz.
Key Differentiating Features. The following technical features of VPI's mmWave amplifier modules are most relevant to the FTO analysis:
(a) Wideband impedance matching using distributed element networks. VPI's broadband matching networks employ non-uniform transmission line segments with continuously tapered impedance profiles, rather than the stepped impedance transformer structures used by some competitors. VPI's approach achieves wideband impedance matching through gradual impedance transitions rather than discrete impedance steps, resulting in broader bandwidth and lower in-band ripple.
(b) Proprietary layout optimization. VPI's MMIC layout algorithms optimize the physical placement and routing of matching network elements to minimize parasitic coupling and maximize thermal uniformity across multi-stage amplifier chains. These algorithms are implemented in VPI's proprietary electronic design automation ("EDA") tools and constitute part of VPI's trade secret portfolio.
(c) Integrated bias sequencing. VPI's amplifier modules incorporate on-chip bias sequencing circuitry that controls the power-up and power-down sequence of the GaN HEMT devices, preventing damage from transient voltage conditions. The bias sequencing approach is covered by several of VPI's mmWave matching network patents.
Relevant VPI Patent Coverage. VPI's mmWave broadband matching network patent family (U.S. Patent Nos. 11,XXX,201 through 11,XXX,220, twenty patents, earliest priority 2018) provides comprehensive coverage of VPI's broadband amplifier architectures. This family is VPI's newest and most actively prosecuted patent family, with several continuation applications still pending. The twenty granted patents in this family cover a range of matching network topologies, layout optimization methods, and bias sequencing techniques.
C. GaN-on-SiC Epitaxial Wafer Processing
Process Description. VPI's in-house MOCVD epitaxial growth process is the foundation of all VPI products. The process involves the sequential deposition of GaN and AlGaN layers on semi-insulating 4H-SiC substrates using metal-organic precursors (trimethylgallium, trimethylaluminum) and ammonia in a vertical-flow MOCVD reactor. VPI's epitaxial process includes proprietary recipes for: (i) a low-temperature aluminum nitride (AlN) nucleation layer that provides lattice matching between the SiC substrate and the GaN buffer; (ii) a carbon-doped GaN buffer layer that provides electrical isolation and high breakdown voltage; and (iii) an undoped GaN channel layer and AlGaN barrier layer that form the 2DEG active region of the HEMT device.
Sensitivity and Trade Secret Status. The specific process parameters of VPI's MOCVD epitaxial growth — including gas flow rates, growth temperatures, chamber pressures, and doping concentrations — constitute VPI's most sensitive trade secrets. These parameters are part of the thirty-one registered trade secrets maintained in VPI's internal trade secret register. The epitaxial growth process is central to VPI's competitive advantage, as the quality and uniformity of the epitaxial layers directly determine device performance, yield, and reliability.
Relevant VPI Patent Coverage. VPI's GaN-on-SiC epitaxial growth process patent family (U.S. Patent Nos. 9,XXX,001 through 9,XXX,008, eight patents, earliest priority 2012) covers VPI's proprietary nucleation layer, buffer layer, and barrier layer processes. While VPI's patents provide important protection, VPI's competitive advantage in this area rests primarily on its trade secrets (i.e., the specific process parameters that are not fully disclosed in the patents) rather than on the patents alone.
Export Control and NSA Relevance. VPI's epitaxial growth process technical data is subject to ITAR and EAR export control restrictions, and the NSA Technology Control Plan will impose additional restrictions on HSAG's access to this data. The FTO analysis of VPI's epitaxial process is relevant to the NSA framework because any third-party IP constraints on VPI's ability to practice its epitaxial process could affect VPI's continued independent operations under the NSA.
IV. THIRD-PARTY PATENT FAMILIES WARRANTING MONITORING
Of the approximately 340 U.S. patents and published applications reviewed in the landscape search (described in detail in Appendix 3), we identified three third-party patent families that warrant ongoing monitoring due to their proximity to VPI's technology. We emphasize at the outset that none of these patent families currently presents an actionable infringement risk. VPI's current products, as presently manufactured and sold, do not practice any claim of any patent in these three families. The families are identified here because of their adjacency to VPI's technology and their potential relevance to VPI's future product development.
Detailed claim charts comparing representative claims from each family against VPI's product features are set forth in Appendix 2. The analysis below summarizes the key findings.
A. Patent Family No. 1 — Apex Microelectronics Corp.
Patent Holder. Apex Microelectronics Corp. ("Apex"), a Delaware corporation with its principal offices in San Jose, California. Apex is a mid-size semiconductor company that designs and manufactures GaN and silicon carbide power devices for automotive and industrial applications. Apex does not have a current business relationship with VPI, and VPI has confirmed that it has never licensed technology from or to Apex.
Patent Family. Apex holds six (6) granted U.S. patents and two (2) pending U.S. patent applications relating to GaN HEMT thermal management structures. The patents are specifically directed to methods for incorporating diamond-based heat-spreading layers in GaN-on-SiC device stacks, with the objective of improving thermal conductivity and enabling higher power density operation.
Earliest Priority Date. 2016.
Representative Patent. U.S. Patent No. 10,XXX,450 — "Thermally Enhanced Gallium Nitride High-Electron-Mobility Transistor with Diamond Heat Spreader" (granted March 12, 2019; earliest priority date September 22, 2016). This patent claims, in its broadest independent claim (Claim 1), a GaN HEMT device comprising:
(a) a silicon carbide substrate;
(b) a diamond or diamond-like carbon heat-spreading layer disposed on the silicon carbide substrate, the heat-spreading layer having a thickness of between 5 micrometers and 50 micrometers;
(c) a gallium nitride buffer layer disposed on the heat-spreading layer;
(d) an aluminum gallium nitride barrier layer disposed on the gallium nitride buffer layer; and
(e) a gate, source, and drain electrode structure formed on the barrier layer.
Dependent claims add further limitations relating to the method of diamond deposition (chemical vapor deposition ("CVD") diamond), the specific thermal conductivity of the diamond layer (greater than 1,000 W/m·K), and the bonding interface between the diamond layer and the GaN buffer.
Relevance to VPI Products. The Apex patents claim specific configurations in which a diamond or diamond-like carbon ("DLC") thermal interface layer is interposed between the GaN epitaxial layers and the SiC substrate. VPI does not currently use diamond heat-spreading layers in any of its production HEMT devices. VPI's current thermal management approach relies on direct GaN-on-SiC epitaxial growth — i.e., the GaN buffer layer is grown directly on the SiC substrate without any intermediate diamond layer — combined with conventional backside via hole thermal management and gold-tin eutectic die attach. VPI's products therefore do not include the "diamond or diamond-like carbon heat-spreading layer" element recited in the independent claims of the Apex patents.
Risk Assessment. The current risk is assessed as low. VPI's existing products do not practice the claimed thermal management structures. However, during the course of our due diligence review, VPI's R&D team disclosed that VPI's technology roadmap includes investigation of diamond-enhanced thermal solutions for next-generation high-power-density GaN devices. Specifically, VPI has allocated internal R&D funding to explore CVD diamond substrate bonding as a potential approach for achieving power densities above 12 W/mm in future defense and space applications. If VPI commercializes products incorporating diamond heat spreaders consistent with the configurations claimed in the Apex patents, these patents could become relevant.
Prosecution History Analysis. Our review of the prosecution history of U.S. Patent No. 10,XXX,450 reveals that Apex was required to narrow its claims during prosecution to distinguish over prior art. The original independent claims were broader, reciting any "thermally conductive layer" between the substrate and the GaN buffer. The examiner rejected these broader claims over a combination of prior art references, and Apex amended the claims to specifically require a "diamond or diamond-like carbon" layer with thickness limitations of "between 5 micrometers and 50 micrometers." These narrowed claims further reduce the risk that VPI's current or near-term products would fall within the claim scope, and they also create a record of prosecution history estoppel that would limit Apex's ability to assert the doctrine of equivalents against non-diamond thermal management approaches.
Litigation History. Apex has not asserted these patents against any party to date. Our review of patent litigation dockets in the District of Delaware, the Eastern District of Texas, and the Western District of Texas did not identify any infringement actions brought by Apex involving these patents or any other patents in Apex's portfolio. We also found no Inter Partes Review ("IPR") proceedings filed against these patents at the Patent Trial and Appeal Board ("PTAB").
Recommendation. We recommend that the Apex patent family be included in the post-closing patent watch program. The watch should monitor: (i) prosecution of the two pending applications for any broadening of claim scope; (ii) any new continuation or divisional applications filed by Apex; (iii) any assertion or licensing activity by Apex; and (iv) VPI's own R&D progress in diamond thermal management. If VPI's R&D advances to the point of incorporating diamond heat spreaders into prototype or production devices, a targeted FTO re-assessment against the Apex patents should be conducted before commercialization.
B. Patent Family No. 2 — Wideband Innovations LLC
Patent Holder. Wideband Innovations LLC ("Wideband"), a Texas limited liability company organized under the laws of the State of Texas. Based on our review of publicly available information, Wideband appears to be a patent licensing entity (commonly referred to as a non-practicing entity or "NPE") that does not manufacture or sell products but rather derives revenue from patent licensing and assertion activities. Wideband's registered agent is located in marshall, Texas. Wideband's patent licensing entity status warrants heightened vigilance, as NPEs are typically more aggressive in asserting patents and less susceptible to defensive cross-licensing strategies.
Patent Family. Wideband holds four (4) granted U.S. patents relating to broadband impedance matching network topologies for millimeter-wave power amplifiers. The patents are specifically directed to multi-section distributed matching networks employing stepped impedance resonators — i.e., matching structures that achieve broadband impedance transformation through a series of transmission line sections with alternating high and low characteristic impedances.
Earliest Priority Date. 2014.
Representative Patent. U.S. Patent No. 10,XXX,780 — "Broadband Matching Network for Millimeter-Wave Power Amplifier Using Cascaded Stepped Impedance Transformers" (granted August 20, 2019; earliest priority date April 3, 2014). The broadest independent claim (Claim 1) recites:
A broadband impedance matching network for a millimeter-wave power amplifier, comprising:
(a) at least three cascaded stepped impedance sections, each section comprising a high-impedance transmission line segment and a low-impedance transmission line segment;
(b) the cascaded sections having progressively decreasing characteristic impedance ratios from an input port to an output port;
(c) the matching network providing an impedance transformation ratio of at least 3:1 over a fractional bandwidth of at least 40%; and
(d) the matching network being implemented in a monolithic microwave integrated circuit.
Relevance to VPI Products. The Wideband patents are directed to stepped impedance transformer matching structures — i.e., structures that achieve broadband matching by concatenating discrete sections of transmission line with alternating high and low impedances. VPI's mmWave broadband matching network designs, as covered by VPI's own patent family (U.S. Patent Nos. 11,XXX,201 through 11,XXX,220), employ a fundamentally different topological approach. VPI's designs use distributed element networks with non-uniform transmission line segments — i.e., transmission lines with continuously tapered impedance profiles — rather than the discrete stepped impedance sections claimed by Wideband. The distinction is not merely semantic: VPI's continuous taper approach achieves impedance matching through a gradual, analog transition, whereas Wideband's claimed approach relies on discrete, digital-like impedance steps.
Risk Assessment. The current risk is assessed as low. Detailed claim analysis, documented in the claim charts at Appendix 2, confirms that Wideband's independent claims require "at least three cascaded stepped impedance sections" with "progressively decreasing characteristic impedance ratios." VPI's distributed matching network designs do not incorporate discrete stepped impedance sections with defined impedance ratios. Instead, VPI's designs employ non-uniform transmission lines in which the impedance varies continuously along the length of the line. This fundamental architectural difference places VPI's designs outside the literal scope of Wideband's claims. We have also considered whether the doctrine of equivalents could bridge this gap, and we conclude that the prosecution history estoppel described below would significantly limit Wideband's ability to invoke the doctrine of equivalents.
Additionally, VPI's own twenty-patent mmWave matching network family (earliest priority 2018) establishes strong prior art positions and documents VPI's alternative design approach in detail. This portfolio provides both a design-around roadmap and significant cross-licensing leverage.
Prosecution History Analysis. The prosecution history of U.S. Patent No. 10,XXX,780 reveals that the USPTO examiner initially rejected Wideband's claims as obvious over a combination of prior art references that disclosed broadband matching networks using various impedance transformation techniques. To overcome the rejection, Wideband was required to amend its independent claims to add the specific structural limitations of "at least three cascaded stepped impedance sections with progressively decreasing characteristic impedance ratios." This amendment narrows the claims to the specific stepped impedance configuration and creates prosecution history estoppel that would preclude Wideband from asserting that non-stepped (e.g., continuously tapered) impedance matching approaches are equivalent to the claimed stepped approach.
Litigation History. Wideband has an active patent assertion history. In 2021, Wideband filed two separate patent infringement actions in the U.S. District Court for the Eastern District of Texas against two other semiconductor companies. However, the patents asserted in those actions were different patents from Wideband's broader portfolio — not the four patents identified here. Both cases settled on undisclosed terms, which makes it difficult to assess the strength or weakness of Wideband's litigation positions. The settlement of both cases without published opinions on claim construction or infringement leaves uncertainty regarding how courts would interpret Wideband's claim language. Notably, Wideband has not yet asserted the specific patents identified in this analysis, but its willingness to litigate and its NPE business model suggest that assertion remains a possibility if Wideband perceives an opportunity.
Recommendation. We recommend that the Wideband patent family be included in the post-closing patent watch program with heightened monitoring given Wideband's patent licensing entity status. The watch should include: (i) monitoring of any new patent assertion or licensing activity by Wideband, including demand letters, licensing campaigns, or litigation filings; (ii) monitoring for any new patents or applications assigned to Wideband; (iii) tracking of the outcomes of any future litigation involving Wideband's portfolio; and (iv) coordination with VPI's in-house counsel to ensure that VPI's product design documentation clearly articulates the non-stepped, continuously tapered nature of VPI's matching network approach. VPI's own twenty-patent mmWave matching network family provides significant counter-assertion leverage; however, because Wideband is a non-practicing entity, it may not be vulnerable to counter-assertion in the same manner as a practicing company. Alternative defensive strategies — including IPR challenges to Wideband's patents based on prior art identified during our search — should be prepared as contingency measures.
C. Patent Family No. 3 — Cerulean Semiconductor Technologies Ltd.
Patent Holder. Cerulean Semiconductor Technologies Ltd. ("Cerulean"), a company organized under the laws of England and Wales, with its registered office in Cambridge, United Kingdom. Cerulean operates a U.S. subsidiary, Cerulean Semiconductor Technologies Inc., incorporated in Delaware, with offices in Research Triangle Park, North Carolina. Cerulean is an operating company that designs and manufactures GaN and silicon carbide power devices for the European defense and telecommunications markets. Cerulean has no current business relationship with VPI.
Patent Family. Cerulean holds five (5) granted U.S. patents and three (3) pending U.S. patent applications relating to GaN epitaxial buffer layer structures. The patents are specifically directed to iron-doped GaN buffer layers engineered for improved breakdown voltage and reduced current collapse in HEMT devices. Iron doping of the GaN buffer layer is one of several known approaches in the art for achieving semi-insulating buffer characteristics; the alternative approaches include carbon doping (VPI's approach), and compensated doping using other deep-level acceptors.
Earliest Priority Date. 2013.
Representative Patent. U.S. Patent No. 9,XXX,920 — "Iron-Doped Gallium Nitride Buffer Layer for High Voltage Power Transistors" (granted November 5, 2017; earliest priority date February 18, 2013). The broadest independent claim (Claim 1) recites:
A high-electron-mobility transistor comprising:
(a) a substrate;
(b) a gallium nitride buffer layer disposed on the substrate, the buffer layer comprising iron dopant atoms at a concentration of between 1×10^17 cm^-3 and 5×10^18 cm^-3;
(c) the iron dopant concentration having a graded profile that decreases from a maximum concentration proximate to the substrate to a minimum concentration proximate to a channel layer;
(d) an undoped gallium nitride channel layer disposed on the buffer layer; and
(e) an aluminum gallium nitride barrier layer disposed on the channel layer.
Relevance to VPI Products. VPI's GaN-on-SiC epitaxial process utilizes a proprietary buffer layer recipe that employs carbon doping — not iron doping — to achieve the semi-insulating characteristics required for HEMT operation. Carbon is incorporated into the GaN buffer layer during MOCVD growth by controlling the growth conditions (temperature, V/III ratio, and growth rate) to achieve the desired carbon incorporation level. VPI does not introduce iron precursors into its MOCVD reactor, and VPI's buffer layers do not contain intentional iron doping at any concentration. The Cerulean patents are specifically directed to iron doping profiles and concentrations in the buffer layer, with the independent claims reciting "iron dopant atoms at a concentration of between 1×10^17 cm^-3 and 5×10^18 cm^-3" as a required claim element.
Risk Assessment. The current risk is assessed as low. VPI's use of carbon doping rather than iron doping in its buffer layer is a fundamental distinction that places VPI's epitaxial process outside the scope of Cerulean's claims. The independent claims of all five granted Cerulean patents require iron doping as an essential element, and VPI's carbon-doped buffer does not satisfy this limitation. VPI's own epitaxial growth process patents (U.S. Patent Nos. 9,XXX,001 through 9,XXX,008) further document VPI's carbon-doped approach and provide prior art coverage that supports VPI's non-infringement position.
Additional Consideration — Pending Applications. Cerulean has three (3) pending U.S. patent applications in this family. These applications are still in prosecution at the USPTO, and the final scope of any claims that may issue from these applications remains uncertain. It is possible that Cerulean may seek claims in the pending applications that are broader than the iron-doping-specific claims in the granted patents — for example, claims that recite any deep-level acceptor doping (which could encompass carbon doping) rather than specifically iron doping. If Cerulean obtains claims with such broader scope, VPI's carbon-doped buffer layer process could potentially fall within the claim scope. However, based on our review of the published applications, the originally filed claims in all three pending applications also recite iron doping as a required element. Any attempt by Cerulean to broaden the claims during prosecution would likely face prior art challenges, given the extensive body of published literature on carbon-doped GaN buffers, including VPI's own published patents and applications.
Prosecution History Analysis. The prosecution history of U.S. Patent No. 9,XXX,920 and the other four granted Cerulean patents reveals that Cerulean was required to narrow its claims during prosecution to require specific iron doping concentrations (1×10^17 to 5×10^18 cm^-3) and graded doping profiles. The original claims were directed more broadly to "doped GaN buffer layers" without specifying the dopant species, but the examiner rejected these claims as anticipated by prior art references disclosing carbon-doped and magnesium-compensated GaN buffers. Cerulean's amendment to require iron doping distinguishes VPI's carbon-doped process from the granted claims and creates prosecution history estoppel that would preclude Cerulean from asserting that carbon doping is equivalent to the claimed iron doping.
Litigation History. Cerulean has not asserted its U.S. patents against any party. However, Cerulean has a corresponding European patent family (EP Patent No. 2,XXX,XXX and related divisionals) that was the subject of opposition proceedings at the European Patent Office ("EPO"). The EPO opposition, filed by an unnamed third party, resulted in the maintenance of the European patent in amended (narrowed) form, with claims limited to specific iron doping profiles. The EPO opposition outcome is consistent with the narrowing of the U.S. patents during prosecution and further supports our assessment that the Cerulean claims are unlikely to encompass VPI's carbon-doped buffer approach.
Recommendation. We recommend that the Cerulean patent family be included in the post-closing patent watch program, with particular attention to the three pending U.S. applications. The watch should monitor: (i) the prosecution progress of the three pending applications, including any office actions, amendments, or allowances; (ii) any broadening of claim scope in the pending applications, particularly any attempt to claim deep-level acceptor doping generally rather than iron doping specifically; (iii) any new continuation or divisional applications filed by Cerulean; and (iv) any assertion or licensing activity by Cerulean. If Cerulean obtains claims in the pending applications that are broader than the currently granted claims, a targeted FTO re-assessment should be conducted.
V. OTHER PATENTS REVIEWED AND CLEARED
A. Summary of Broader Search Results
The patent landscape search described in Section II.D resulted in the identification and initial review of approximately 340 U.S. patents and published applications with potential relevance to VPI's product lines and manufacturing processes. A complete listing of all patents and applications reviewed, including assignee, title, priority date, and disposition, is provided in Appendix 3.
Of the approximately 340 patents reviewed, approximately 85 were subjected to detailed claim analysis based on an initial relevance screening that assessed the proximity of the patent's subject matter to VPI's specific product architectures and process parameters. The remaining approximately 255 patents were cleared at the initial screening stage based on one or more of the following factors: (i) the patents were directed to device architectures or material systems (e.g., GaAs, InP, silicon LDMOS) that are not used by VPI; (ii) the patents were directed to applications (e.g., power electronics, LED lighting, solar cells) outside VPI's product scope; (iii) the patents had expired or were scheduled to expire before 2025; or (iv) the patents' claims were clearly distinguishable from VPI's products based on facially apparent claim limitations.
Of the approximately 85 patents subjected to detailed claim analysis, three patent families were identified as warranting ongoing monitoring, as discussed in Section IV above. The remaining approximately 82 patents were cleared following detailed claim analysis. No patent other than those three families was identified as presenting a meaningful FTO risk to VPI's current or near-term product lines.
B. Categories of Cleared Patents
The cleared patents fell into several broad categories, summarized below:
GaN Device Fabrication Process Patents. The search identified multiple third-party patents relating to GaN MOCVD growth processes, including patents covering specific nucleation layer structures, buffer layer compositions, and barrier layer designs. VPI's specific MOCVD process parameters — including its proprietary AlN nucleation layer recipe, carbon-doped buffer layer approach, and AlGaN barrier layer composition — distinguish VPI's process from the claimed methods in the identified third-party patents. In particular, VPI's nucleation layer process employs a two-stage growth approach (low-temperature AlN nucleation followed by high-temperature AlN regrowth) that differs from the single-stage or multi-layer nucleation approaches claimed in the prior art. Similarly, VPI's carbon-doped buffer layer approach — documented extensively in VPI's own patents — is distinct from the iron-doped, magnesium-compensated, or undoped buffer approaches claimed in many third-party patents. The only buffer-layer-related patents that warranted further analysis were the Cerulean patents discussed in Section IV.C.
Power Amplifier Circuit Design Patents. The search revealed a broad landscape of patents in the field of RF and microwave amplifier design, including patents covering various amplifier topologies (e.g., Doherty, balanced, distributed), bias circuit configurations, and linearization techniques. VPI's specific MMIC layout topologies and bias network architectures do not implicate the identified third-party claims. VPI's amplifier designs are covered by its own mmWave matching network patent family, which documents VPI's proprietary design approach in detail. The only amplifier-design-related patents that warranted further analysis were the Wideband Innovations patents discussed in Section IV.B.
Packaging and Assembly Patents. VPI's die-attach, wire-bonding, and module packaging methods were reviewed against third-party patents covering advanced semiconductor packaging techniques, including flip-chip bonding, embedded die packaging, and advanced thermal interface materials. No relevant overlap was identified between VPI's packaging methods and the identified third-party claims. VPI's packaging approach is relatively conventional (gold-tin eutectic die attach, gold wire bonding, hermetically sealed ceramic packages for defense applications) and does not implicate the more novel packaging patents identified in the search.
SiC Substrate Preparation Patents. The search identified several patents relating to the preparation of semi-insulating SiC substrates, including methods for controlling substrate resistivity, surface polishing, and defect reduction. VPI procures its SiC substrates from established U.S. and allied-nation suppliers, as detailed in the VPI Supply Chain Map prepared by the deal team. To the extent any SiC substrate preparation patents are relevant, the infringement risk would reside with VPI's substrate suppliers rather than with VPI itself, as VPI does not manufacture its own SiC substrates. VPI's supply agreements include customary intellectual property indemnification provisions from its substrate suppliers, which would provide an additional layer of protection in the event of a substrate-level patent dispute.
VI. IMPACT OF GOVERNMENT CONTRACTOR STATUS ON FTO RISK
As noted in Section II.C, the government contractor defense under 28 U.S.C. § 1498 provides significant protection for a substantial portion of VPI's product output. This section elaborates on the scope and significance of that protection.
Statutory Framework. Under 28 U.S.C. § 1498(a), whenever an invention described in and covered by a U.S. patent is used or manufactured by or for the United States without license of the owner or lawful right to use or manufacture the same, the owner's remedy shall be by action against the United States in the United States Court of Federal Claims. This provision applies to government contractors who manufacture patented articles for and deliver them to the U.S. government with the government's authorization or consent. The practical effect is that the patent holder cannot sue the contractor directly for infringement; instead, the patent holder must proceed against the United States government, and the contractor is shielded from liability.
Application to VPI. VPI's fourteen active DoD contracts involve the manufacture and delivery of GaN power amplifier devices, modules, and subsystems to various U.S. government agencies and their prime contractors. For all products manufactured and delivered under these contracts, VPI would be entitled to invoke the § 1498 defense in the event of a patent infringement claim. This defense covers VPI's AN/TPS-80 radar GaN power modules (Army CERDEC / PEO IEW&S), missile defense T/R modules (MDA), next-generation mmWave power amplifiers (AFRL), border surveillance RF components (DHS S&T), and products supplied under the Ironclad Defense Systems / NAVSEA subcontract.
Scope Limitations. The § 1498 defense does not extend to VPI's commercial sales. VPI sells GaN HEMT devices and mmWave amplifier modules to commercial customers for 5G wireless infrastructure applications, including base station amplifiers and small-cell backhaul equipment. These commercial sales are not made for or on behalf of the U.S. government and would therefore be subject to standard patent infringement liability in the U.S. district courts. VPI's commercial 5G revenue is a growing but still relatively modest portion of its overall business; nonetheless, the FTO analysis has been conducted to cover both government and commercial product lines.
Significance for Risk Assessment. VPI's government contract backlog of $193 million represents a substantial portion of VPI's total revenue and near-term business pipeline. The availability of the § 1498 defense for this government-contracted production meaningfully reduces VPI's overall FTO risk profile. In effect, even if a third-party patent were found to cover VPI's products, the patent holder could not obtain an injunction against VPI's government-contract production and could not recover damages from VPI for government-contract sales. The patent holder's sole recourse would be a claim against the United States for reasonable and entire compensation.
Conservative Approach. Despite the significant protection afforded by § 1498, we have conducted the FTO analysis presented in this memorandum without reliance on the government contractor defense. This approach ensures that HSAG receives the most comprehensive and conservative risk assessment possible, accounting for both VPI's government and commercial product lines. The § 1498 defense represents an additional layer of protection that further mitigates the already-low FTO risk identified in our analysis.
VII. IMPLICATIONS FOR NSA AND TECHNOLOGY CONTROL PLAN
The CFIUS review process and the anticipated NSA and Technology Control Plan impose certain restrictions on HSAG's access to and use of VPI's intellectual property. While the detailed analysis of these restrictions is set forth in Peggy Ashworth's NSA/TCP negotiation memoranda and in the IP Transfer Restriction Analysis memo, we note here the FTO-related implications.
Access Restrictions. The NSA's Technology Control Plan provisions will restrict HSAG's ability to access VPI's detailed technical data, including patent prosecution files, trade secret documentation, and R&D data, without U.S. government authorization. This means that HSAG's parent company in Dresden will not have unrestricted access to the detailed claim charts, design-around memoranda, and engineering analyses that support VPI's FTO positions. VPI's FTO-related documentation — including the appendices to this memorandum — should be maintained within VPI's U.S. operations and accessible only to personnel with appropriate authorizations under the TCP.
IP Transfer Restrictions. The NSA will limit HSAG's ability to integrate VPI's patented technology into HSAG's non-U.S. product lines. This restriction is relevant to the FTO analysis because it means that the third-party patent risks identified in this memorandum will remain confined to VPI's U.S. operations. HSAG's European and Asian product lines will not incorporate VPI's GaN technology (absent specific U.S. government authorization), and therefore the third-party patent families identified in Section IV will not be relevant to HSAG's non-U.S. operations.
Continued Independent Operations. The FTO analysis does not identify any third-party rights that would impede VPI's continued independent operations under the NSA framework. VPI's existing product lines can continue to be manufactured and sold within the existing patent landscape without licensing or design modifications. This conclusion supports the viability of the "VPI-as-independent-U.S.-subsidiary" operational model contemplated by the NSA.
R&D Oversight. Post-closing, any VPI R&D activities that might bring VPI closer to the third-party patent families identified in Section IV should be flagged for FTO review before commercialization. The VPI Government Security Committee ("GSC"), composed of the three Security Board Members required under the NSA, would have oversight of classified R&D programs. However, unclassified commercial R&D — including VPI's investigation of diamond thermal management solutions and any modifications to its epitaxial buffer layer processes — should also be subject to IP counsel review through VPI's in-house legal team or outside IP counsel. We recommend that VPI's internal R&D review process include a mandatory FTO checkpoint for any new product design or significant design modification, with findings reported to the GSC as appropriate.
VIII. RECOMMENDATIONS
Based on the analysis presented in this memorandum, we make the following recommendations.
A. No Current Litigation or Licensing Action Required
We conclude that VPI's current products and manufacturing processes do not infring